Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 DNA polymerase theta protects leukemia cells from metabolic-induced DNA damage..  Blood.  2022
2022 The Expression Pattern of Adhesion G Protein-Coupled Receptor F5 Is Related to Cell Adhesion and Metastatic Pathways in Colorectal Cancer—Comprehensive Study Based on In Silico Analysis.  Cells.  11. 2022
2021 TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors..  Cancer Research.  81:5089-5101. 2021
2021 The Emerging Role of Suppressors of Cytokine Signaling (SOCS) in the Development and Progression of Leukemia..  Cancers.  13. 2021
2021 RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia..  Journal of Clinical Investigation.  131. 2021
2021 Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche..  Frontiers in Cell and Developmental Biology.  9:767510. 2021
2019 Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.  Cancer Science.  110:1931-1946. 2019
2018 Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent..  Oncotarget.  9:36867-36877. 2018
2018 High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL..  SLAS Discovery.  23:732-741. 2018
2018 Drugging DNA repair to target T-ALL cells. 2018
2018 Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.  Cell Reports.  23:3127-3136. 2018
2018 Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy..  PLoS One.  13:e0193849. 2018
2018 Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL..  Biomarker Research.  6:27. 2018
2017 Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia..  Pediatric Blood and Cancer.  64. 2017
2017 Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia..  Pediatric Blood and Cancer.  64. 2017
2017 CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS..  Leukemia.  31:255-258. 2017
2016 Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia..  Science Signaling.  9:ra116. 2016
2016 MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A Children's Oncology Group Study.  Leukemia.  30:1909-1912. 2016
2016 Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia..  Oncotarget.  7:33960-33982. 2016
2014 Pyrosequencing for classification of human FcγRIIIA allotypes: a comparison with PCR-based techniques..  Molecular Diagnosis and Therapy.  18:665-673. 2014
2014 The antioxidants, vitamin A and E but not vitamin C and melatonin enhance the proapoptotic effects of irinotecan in cancer cells in vitro..  Toxicology in Vitro.  28:282-291. 2014
2013 Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies..  Leukemia.  27:1263-1274. 2013
2011 GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia..  Leukemia.  25:1135-1146. 2011
2011 Evaluation of cytotoxicity of new trans-palladium(II) complex in human cells in vitro..  Acta poloniae pharmaceutica.  68:127-136. 2011
2010 The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis..  BMC Microbiology.  10:329. 2010
2010 Genotoxic effects of irinotecan combined with the novel platinum(II) complexes in human cancer cells..  Chemico-Biological Interactions.  188:66-74. 2010
2008 Identification of components of the sigma B regulon in Listeria monocytogenes that contribute to acid and salt tolerance..  Applied and Environmental Microbiology.  74:6848-6858. 2008
2007 Analysis of aclarubicin-induced cell death in human fibroblasts..  Cell Biology International.  31:1049-1056. 2007
2007 Genotoxicity of novel trans-platinum(II) complex with diethyl (pyridin-4-ylmethyl)phosphate in human non-small cell lung cancer cells A549..  Chemico-Biological Interactions.  168:135-142. 2007
2005 Synthesis, spectroscopy and antiproliferative activity of cis- and trans-platinum(II) complexes with diethyl (pyridin-4-ylmethyl)phosphate. X-ray crystal structure of trans-Pt(II) complex..  Journal of Inorganic Biochemistry.  99:2024-2031. 2005

Education And Training

  • Doctor of Philosophy Level Degree in Biology / Biological Sciences, University of Lodz 2007

    • Full Name

  • Ksenia Matlawska-Wasowska